SABBY MANAGEMENT, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$89,000
-93.5%
14,029
-95.1%
0.01%
-82.7%
Q1 2018$1,360,000
+1273.7%
286,800
+225.9%
0.08%
+1925.0%
Q3 2016$99,000
-89.8%
87,999
-86.7%
0.00%
-92.2%
Q2 2016$974,000
-36.5%
662,467
-38.2%
0.05%
-33.8%
Q1 2016$1,534,000
-13.9%
1,072,765
-1.3%
0.08%
-21.4%
Q4 2015$1,782,000
+3140.0%
1,086,615
+6759.1%
0.10%
+4800.0%
Q4 2014$55,00015,8420.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Benchmark Capital Advisors 221,700$1,051,0000.83%
EAM Global Investors LLC 227,063$1,076,0000.56%
EAM Investors, LLC 319,187$1,513,0000.25%
COURAGE CAPITAL MANAGEMENT LLC 30,000$142,0000.11%
Cutter & CO Brokerage, Inc. 53,600$254,0000.10%
SABBY MANAGEMENT, LLC 286,800$1,360,0000.08%
D.A. DAVIDSON & CO. 731,300$3,466,0000.07%
Tibra Equities Europe Ltd 63,414$301,0000.05%
Advisor Group, Inc. 556,377$2,637,0000.04%
Laurel Wealth Advisors, Inc. 21,400$101,0000.03%
View complete list of GALECTIN THERAPEUTICS INC shareholders